RATIO-TOPISALIC LOTION

Krajina: Kanada

Jazyk: angličtina

Zdroj: Health Canada

Aktívna zložka:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE); SALICYLIC ACID

Dostupné z:

TEVA CANADA LIMITED

ATC kód:

D07XC01

INN (Medzinárodný Name):

BETAMETHASONE

Dávkovanie:

0.5MG; 20MG

Forma lieku:

LOTION

Zloženie:

BETAMETHASONE (BETAMETHASONE DIPROPIONATE) 0.5MG; SALICYLIC ACID 20MG

Spôsob podávania:

TOPICAL

Počet v balení:

30ML/60ML

Typ predpisu:

Prescription

Terapeutické oblasti:

ANTI-INFLAMMATORY AGENTS

Prehľad produktov:

Active ingredient group (AIG) number: 0215695003; AHFS:

Stav Autorizácia:

APPROVED

Dátum Autorizácia:

2013-02-22

Súhrn charakteristických

_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 1 of 20_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
PR
RATIO-TOPISALIC
Betamethasone Dipropionate (0.5 mg / g as base)
and Salicylic Acid (20 mg / g)
LOTION
TOPICAL CORTICOSTEROID AND KERATOLYTIC
TEVA CANADA LIMITED
Date of Revision:
30 Novopharm Court
April 17, 2020
Toronto, Ontario,
Canada M1B 2K9
www.tevacanada.com
Submission Control No: 235690
_ _
_ratio-TOPISALIC Lotion (Betamethasone Dipropionate and Salicylic
Acid) _
_ _
_Page 2 of 20_
TABLE OF CONTENTS
TABLE OF CONTENTS
.............................................................................................................
2
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
1
INDICATIONS
.................................................................................................................
3
1.1
Pediatrics
...................................................................................................................
3
1.2
Geriatrics
...................................................................................................................
3
2
CONTRAINDICATIONS
................................................................................................
3
3
DOSAGE AND ADMINISTRATION
............................................................................
3
3.1
Dosing Considerations
..............................................................................................
3
3.2
Recommended Dose and Dosage Adjustment
.......................................................... 4
4
MISSED DOSE
.................................................................................................................
4
5
OVERDOSAGE
................................................................................................................
4
6
DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING .............. 4
7
WARNINGS AND PRECAUTIONS
..............................................